XPRA:TABAK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XPRA:TABAK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Philip Morris CR AS XPRA:TABAK
Philip Morris CR AS XPRA:TABAK 83 Days Payable is 34.03 as of Dec. 2025, which is 71% above its 10-year median of 19.88. GuruFocus rates XPRA:TABAK with a GF Score™ of 83/100 and a GF Value™ of Kč17,569.77 (Fairly Valued). The stock has 6 warning signs investors should review. Among 47 Tobacco Products companies, Philip Morris CR AS ranks worse than 72.34% on this metric.
Philip Morris CR AS's average Accounts Payable for the six months ended in Dec. 2025 was Kč1,183 Mil. Philip Morris CR AS's Cost of Goods Sold for the six months ended in Dec. 2025 was Kč6,341 Mil. Hence, Philip Morris CR AS's Days Payable for the six months ended in Dec. 2025 was 34.03.
The historical rank and industry rank for Philip Morris CR AS's Days Payable or its related term are showing as below:
During the past 13 years, Philip Morris CR AS's highest Days Payable was 64.39. The lowest was 9.88. And the median was 19.88.
Philip Morris CR AS's Days Payable declined from Dec. 2024 (37.51) to Dec. 2025 (34.03). It may suggest that Philip Morris CR AS accelerated paying its suppliers.
The historical data trend for Philip Morris CR AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Philip Morris CR AS Annual Data | |||||||||||||||||||||
| Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||||
| Days Payable | Get a 7-Day Free Trial |
|
|
22.20 | 26.54 | 53.49 | 64.39 | 52.42 | |||||||||||||
| Philip Morris CR AS Semi-Annual Data | ||||||||||||||||||||
| Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | Dec24 | Jun25 | Dec25 | |
| Days Payable | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
50.67 | 53.03 | 37.51 | 35.28 | 34.03 | ||
For the Tobacco subindustry, Philip Morris CR AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Tobacco Products industry and Consumer Defensive sector, Philip Morris CR AS's Days Payable distribution charts can be found below:
* The bar in red indicates where Philip Morris CR AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Philip Morris CR AS's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
| Days Payable (A: Dec. 2025 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (A: Dec. 2024 ) | + | Accounts Payable (A: Dec. 2025 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2025 ) | * | Days in Period |
| = | ( (1784 | + | 1790) | / | 2 ) | / | 12442 | * | 365 |
| = | 1787 | / | 12442 | * | 365 | ||||
| = | 52.42 |
Philip Morris CR AS's Days Payable for the quarter that ended in Dec. 2025 is calculated as:
| Days Payable (Q: Dec. 2025 ) | |||||||||
| = | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
| = | ( (Accounts Payable (Q: Jun. 2025 ) | + | Accounts Payable (Q: Dec. 2025 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2025 ) | * | Days in Period |
| = | ( (575 | + | 1790) | / | 2 ) | / | 6341 | * | 365 / 2 |
| = | 1182.5 | / | 6341 | * | 365 / 2 | ||||
| = | 34.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Based on GuruFocus' analysis, Philip Morris CR AS stock appears to be overvalued. The current stock price of Kč18,200.00 is trading 3.6% above its estimated GF Value™ of Kč17,569.77. GuruFocus considers Philip Morris CR AS to be Fairly Valued.
Key valuation signals for XPRA:TABAK:
No single metric tells the full story. See the XPRA:TABAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.